Integrated multi-omics, network pharmacology, and experimental validation reveal the protective mechanisms of curcumol against DSS-induced ulcerative colitis
BackgroundUlcerative colitis (UC) is a chronic relapsing inflammatory bowel disease characterized by mucosal immune imbalance, epithelial barrier disruption, and intestinal dysbiosis. Curcumol (CUR) possesses anti-inflammatory and immunomodulatory acti…